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Abstract
Drug tolerance and withdrawal are insidious responses to drugs of abuse; the first increases drug consumption while
the second punishes abstention. Drosophila generate functional tolerance to benzyl alcohol sedation by increasing
neural expression of the slo BK-type Ca2+ activated K+ channel gene. After drug clearance this change produces a
withdrawal phenotype—increased seizure susceptibility. The drug-induced histone modification profile identified the
6b element (60 nt) as a drug responsive element. Genomic deletion of 6b produces the allele, sloΔ6b, that reacts more
strongly to the drug with increased induction, a massive increase in the duration of tolerance, and an increase in the
withdrawal phenotype yet does not alter other slo-dependent behaviors. The 6b element is a homeostatic regulator of
BK channel gene expression and is the first cis-acting DNA element shown to specifically affect the duration of a drug
action.
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Introduction
Drug tolerance and withdrawal symptoms are two of the
seven criteria used to diagnose addiction in humans [1]. These
two responses are central features of the addicted state and
have long been proposed to be two faces of the same
homeostatic response [2]. The very adaptations that generate
functional tolerance, a reduction in the response to a drug
caused by prior drug exposure, also generate an abnormal,
typically opposite effect once the drug is cleared. For example,
tolerance to a drug that suppresses neural activity could be
produced by changes in gene expression that make the
nervous system more excitable. However, when the drug is no
longer present these changes produce an overly excitable
nervous system. Such changes could underlie the long-
recognized behavior of an addict or alcoholic who upon
abstention begins to shake, is unable to sleep, and may even
have seizures [3].
We use the Drosophila model system and the organic
solvent anesthetic benzyl alcohol to understand the
homeostatic regulatory mechanisms that produce functional
tolerance to organic solvent sedation. Because of its low
toxicity, benzyl alcohol has been used to model the neural
effects of organic solvent exposure in the Drosophila model
system [2]. Drosophila generate functional tolerance to
sedation by the anesthetic benzyl alcohol by increasing neural
expression of the slo BK channel gene [4]. By reducing the
neural refractory period, the increase in slo expression acts as
a neural excitant and counters the sedating effects of the drug
[5]. While the change helps to counter the effects of the
anesthetic, after drug clearance it produces a withdrawal
phenotype by continuing to promote excitability, thus increasing
the seizure susceptibility of the fly.
To determine how the transcriptional control region of the slo
gene senses drug sedation, we previously mapped the position
of a drug-induced histone modification under the assumption
that these modifications mark sites of transcription factor
activity and that the underlying DNA would contain functionally
important DNA enhancers [6]. One such strong and focused
drug-induced histone acetylation spike was situated between
the two neural-specific core promoters and has been closely
correlated with both drug-induction of slo expression and the
appearance of behavioral tolerance. The DNA underlying this
position includes a highly conserved 60 nt DNA element called
element 6b (Figure 1A). This element was mutated in situ and
shown to have a profound effect on the response to benzyl
alcohol sedation.
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Results
The 6b evolutionarily conserved DNA element was
previously proposed to be involved in benzyl alcohol regulation
of the slo gene (reference [6] and summarized in Figure 1A).
Because DNA regulatory elements can have context-specific
effects we chose to delete the element from its chromosomal
position and determine how its removal affects slo gene
expression.
Removal of the 6b element from the slo promoter
region
Homologous recombination [7] was used to replace the sixty-
nucleotide element 6b in the endogenous gene with a single
loxP site (Figure 1B-C). Correct targeting events were verified
by genetic linkage, Southern blotting (Figure 1D), and DNA
sequencing. This allele, called slo∆6b was backcrossed into the
wild-type Canton S background for six generations to minimize
genetic differences between the mutant and wild-type lines.
Figure 1.  Modification of the slo transcriptional control region.  A) Transcriptional control region of slo. Labelled arrows are
tissue-specific transcription start sites of the previously-described promoters [11]. Blue boxes represent alternative 5' exons that are
unique products of each promoter. Rightmost box on the line represents the first exon common to all slo transcripts. Neuronal splice
variants begin translation in this exon. The remainder of the coding region is not shown. Boxes below the line are non-coding
conserved DNA elements [11,40,41]. The table summarizes benzyl alcohol induced histone H4 hyper-acetylation, neural expression
of slo, and functional tolerance (data from Wang et al. [6]). Plusses correspond to the H4 hyperacetylation. Arrows reflect relative
abundance of slo mRNA (RNA). Checks identify when behavioral tolerance can be detected in the first 48 h (Tol). B) Homologous
recombination occurred between the replacement DNA (red) and its chromosomal counterpart (blue) replaces 6b with a floxed mini-
white gene. Cre recombinase was used to excise the loxP-flanked white gene to produce the slo∆6b allele in which the 6b element
has been replaced by a loxP site. C) Crossing scheme for 6b targeting. D) Products produced at the different steps in the crossing
scheme described in panel C. E) Southern blotting confirms homologous recombination into the slo locus. Restriction maps of wild
type, slow∆6b, and slo∆6b. Probe indicated above maps. The recipient line (WT), produces an 8.5 kb band. The slow∆6b and slo∆6b
recombinants produce bands whose size is indicative of high fidelity homologous recombination into at the position of the 6b
element (cf. panels D and E).
doi: 10.1371/journal.pone.0075549.g001
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The slo∆6b homozygotes are healthy with no obvious physical
abnormalities nor deficiencies in growth rate or development.
All of the original seven slo mutant alleles are believed to be
null mutations, either failing to express protein or producing a
protein that fails to assemble into a functional channel [8]. The
null alleles were identified based on the so-called "sticky-feet"
phenotype in which a short stimulation with heat followed by a
return to ambient temperature causes the mutants to behave
as if their feet are stuck to the surface upon which they stand
[8,9]. In addition, without any sort of pretreatment, a slo null
mutation also produces other subtle behavioral abnormalities.
These include changes in overall activity, walking speed,
climbing ability, capacity for flight, and circadian rhythmicity
(shown in Figure 2 for the slo4 null allele; some of these
behavioral changes have been previously described [9,10]).
Homozygous slo∆6b mutants do not show these phenotypes. As
displayed in Figure 2A-G, homozygous slo∆6b mutants are
indistinguishable from wild type for these behaviors. The slo∆6b
allele also shows normal intrinsic sensitivity to sedation with
benzyl alcohol (Figure 2H).
slo∆6b mutants transcriptionally overreact to drug
sedation
In the fly, neural expression of slo is the product of two core
promoters C0 and C1 (Figure 1) [11]. Transcripts from core
promoter C0 begin with a 37 nt exon that has been called exon
C0, while transcripts from core promoter C1 begin with a 433 nt
exon called exon C1. In the pre-mRNA, exon C0 is spliced to
exon C1 [11]. Thus, quantifying the relative abundance of exon
C1 in the mRNA pool reports the neural-specific expression
level of the slo gene although it does not report the relative
contribution of the two neural-specific core promoters. Bohm et
al. [11] used RNAase protection assays to show that the ratio
of C0 to C1 transcripts is 12:1. Because the slo∆6b mutation is
within the intronic region separating exon C0 and exon C1, we
were concerned that the mutation might interfere with the
splicing of exon C0 to exon C1. To evaluate this possibility, we
performed RT-PCR using a 5' PCR primer within exon C0 and
a 3' PCR primer within exon C1. Amplification with this primer
pair produced a product of the predicted size for a properly
spliced mRNA, demonstrating that slo∆6b does not completely
disrupt splicing of the C0-specific transcript (Figure 2I).
However, it is possible that a small change in splicing efficacy
has occurred.
We used RT-qPCR (reverse-transcription quantitative PCR)
to quantify the relative abundance of slo mRNA in head-
specific mRNA expressed from the neural promoters of the
mutant before and after benzyl alcohol sedation. In animals
that had never been sedated, the mutant displayed the same
relative abundance of neural slo mRNA as did the wild type
(Figure 2J), indicating that removal of the 6b element did not
affect the basal rate of slo transcription. However, 6 hours after
benzyl alcohol sedation, slo mRNA abundance was induced to
a substantially higher level in the mutant than in the wild type
(150% vs. 60% induction, respectively; Figure 3A,B). However,
the duration of induction appears similar. At 24 h post sedation
the mRNA abundance of both the wild type and the mutant are
not statistically different from the baseline (Figure 3C,D).
slo∆6b mutants acquire abnormally prolonged tolerance
One would expect that an increase in slo induction would
result in a corresponding increase in the magnitude or duration
of functional tolerance. While we did not observe an increase in
the magnitude of 24 h tolerance, this might be because the
response has saturated or because the assay is not well-suited
for capturing the absolute magnitude of tolerance [4]. However,
the mutation was observed to produce a profound difference in
the duration of tolerance (Figure 4). In the time-course assay,
we varied the interval between the first drug sedation and the
tolerance assay from 1 day to 4, 7, 14, 21, and 28 days.
Tolerance in the wild type persisted for less than 14 days,
whereas the mutant still showed strong tolerance even 28 days
after a single drug exposure. In fact, at the 28-day time point,
while the mutant still showed substantial tolerance, the wild
type exhibited the opposite response: sensitization to drug
sedation. Tolerance was not assayed after 28 days because
aging and mortality compromised the assay for both wild type
and mutant. Recombinants that retained the 6b element but
that carried an adjacent loxP insertion did not produce
prolonged tolerance. In addition, loxP sequences have not
been reported to be transcriptionally active. Therefore, we
conclude that the increase in the duration of tolerance is
caused by the absence of the sixty-nucleotide 6b element and
not the presence of the loxP site.
Prolonged tolerance might be caused by a pulsatile
reactivation of the gene that maintains an elevated level of BK
channel activity. However, a time-course analysis that
monitored slo mRNA abundance in the nervous system from 6
h to 28 d after a single benzyl alcohol sedation (6 h, 1 d, 4 d, 7
d, 14 d, 21 d and 28 d) did not show evidence of an additional
round of slo induction (Figure 5). It appears that the abnormal
longevity of tolerance is the product of a single burst of slo
expression. However, we cannot rule out the possibility that
elevated slo expression is maintained in a minor but critical
populations of neurons.
Histone acetylation by transcription factors is a common step
in gene activation and plays an important role in drug addiction
[12]. Previously, we surveyed the histone H4 acetylation state
to monitor the unfolding transcriptional program induced by
benzyl alcohol sedation and identified element 6b as the
location of a hyperacetylated spike observable 24 h after
sedation [6]. There are also histone acetylation spikes over C1
and C0 at 6 h but not 24 h after sedation. The spike at C1 is
probably merely part of the 6b spike since these two regions
are contiguous. However, the spike at C0 is not continuous
with 6b and probably is connected to transcription from the
neural-specific promoter C0. Here we examined the drug-
induced histone acetylation pattern in slo∆6b to ask how the loss
of the 6b element affects this response. The histone acetylation
pattern was assayed in a chromatin immunoprecipitation real-
time PCR assay (ChIP-qPCR) using an antibody that
recognizes all forms of histone H4 acetylation. At 6 h post
sedation, the mutant lacks the wild-type acetylation spikes
across the original position of element 6b and core promoter
C1 although it shows strong acetylation at core promoter C0. At
24 h post sedation, the mutant lacks the acetylation spike at
the position of 6b and instead shows significantly elevated
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Figure 2.  slo∆6b flies are normal with respect to most behaviors.  The slo∆6b strain was backcrossed to the Canton S wild-type
stock (WT) for six generations prior to analysis. The locomotor activity, (A), walking speed (B), climbing (C) and flight (D) of slo∆6b
are similar to WT, while the slo4 null mutants are deficient in all four behaviors. E) Circadian activity. LD entrained flies were
transferred to DD and monitored. WT and slo∆6b flies demonstrated rhythmic oscillation in activity. slo∆6b had slightly higher peak
activity than WT. However, the slo4 null mutants were arrhythmic. n=25. F) Percentage of WT, slo∆6b, and slo4 identified as rhythmic.
G) slo∆6b mutants had a normal circadian period length. n=25. H) The slo∆6b mutation does not alter drug resistance. Age-matched
females were BA sedated and their recovery rate was determined. n=6. I) The slo∆6b mutation, does not disturb the splicing out of
the intron in which it is located. RT-PCR shows that the flanking exons are spliced normally. J) The slo∆6b allele shows normal basal
expression level (P=0.859; n=3). mRNA abundance was measured by RT-qPCR using primers specific for neuronal slo transcripts.
Statistical tests. A, B, C, and F–one-way ANOVA with Dunnett’s comparison post test. *** indicates P≤ 0.001. N=25 (A), 3 (B), and
4 (C). For H, the log-rank test was used to evaluate significance between the recovery curves. For J, an unpaired t-test was used to
evaluate significance. All error bars are SEM.
doi: 10.1371/journal.pone.0075549.g002
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acetylation at the two neural-specific promoters (core promoter
C0 and core promoter C1; Figure 6).
The slo∆6b mutation increases the physiological
response to drug sedation
Increased slo BK channel gene expression has been shown
to act as a neural excitant that both counters the effects of
organic solvent sedation, producing tolerance, and increases
the probability of seizures after sedation [5]. In comparison to
the wild type, slo∆6b mutants show increased slo induction
following drug sedation and a concomitant increase in the
duration of drug tolerance. Therefore, we asked whether the
slo∆6b mutation would also exacerbate the post-sedation
susceptibility to seizure phenotype. Trains of high-frequency
electroconvulsive shock (ECS) delivered at escalating voltages
were used to induce a stereotypical seizure response (Figure
7A) that is characterized by a spontaneous initial discharge
followed by a period in which the neurons fail to respond and a
delayed secondary discharge [13,14]. The seizure threshold
voltage has been used as a measure of seizure susceptibility
and is defined as the lowest stimulus voltage needed to induce
a seizure.
Before sedation, the baseline seizure threshold was 34.4 ±
2.1 V in the wild type and 23.1 ± 3.1 V in slo∆6b. This is the first
indication of a change in a baseline response caused by the
slo∆6b mutation. Twenty-four hours after benzyl alcohol
sedation, the mutant showed a larger drug-induced change
than the wild type showed. After benzyl alcohol sedation, the
seizure threshold potential of the wild type was reduced from
34.4 ± 2.1 V to 24.4 ± 2.4 V, while the mutant showed a
reduction from 23.1 ± 3.1 V to 12.8 ± 1.2 V (Figure 7B). To
better compare the drug-induced response, the percentage
decrease in seizure threshold was calculated by normalizing
the voltage reduction by the basal seizure threshold voltage.
Wild-type flies showed a drug-induced reduction of 29.0 ± 3.2%
in seizure threshold, whereas the percentage change in seizure
threshold in slo∆6b was 51.0 ± 4.2% (Figure 7C). The seizure
threshold of both wild type and mutant had returned to baseline
by 7 d post-drug sedation (Figure 7D& E). In addition, at the
7 d and 14 d time points we noted that there was an age-
related reduction in seizure threshold in the wild type and that
by 14 d post sedation all of the seizure thresholds had
converged (Figure 7F).
Discussion
This work represents the unusual discovery of a cis-acting
DNA regulatory element that specifically participates in a
complex behavioral response to a drug. The slo gene
expresses BK-type Ca2+ activated K+ channels in most neurons
of the CNS [15]. In accordance with this broad expression
pattern, loss-of-function mutations in slo are behaviorally
pleiotropic. These animals are uncoordinated, fly poorly, lack
circadian rhythms, exhibit sticky-feet paralysis, are slightly
resistant to seizures, and fail to acquire rapid tolerance to
sedation with organic solvents such as benzyl alcohol and
ethanol [4,9,10,16]. Sedation of flies with organic solvents was
shown to homeostatically induce expression of the slo gene,
which generates tolerance to sedation by these drugs and a
withdrawal response [4,17]. The 6b element, positioned
between the two neural core promoters of the slo gene,
appears to be specifically involved in the drug-induced
homeostatic regulation of neural expression. To date, the only
behaviors observed to be affected by removal of the 6b
element are drug-related responses—functional drug tolerance
and drug-induced increase in seizure susceptibility. The effect
of the mutation on basal expression from the gene appears to
be minimal because the mutant animal is largely behaviorally
normal and because slo∆6b homozygotes have the same
relative abundance of neural-specific slo transcripts.
With regard to drug responses, the slo∆6b allele behaves as a
gain-of-function mutation. Wild-type animals respond to benzyl
alcohol sedation with an increase in slo neural expression that
Figure 3.  The slo∆6b mutation specifically affects drug-induced neural expression of slo.  A) Six hours after benzyl alcohol
sedation induction slo expression is increased in the wild type (CS) and slo∆6b mutants; however, induction is greater in the mutant
than in the wild type. B) The relative abundance of slo mRNA was not statistically different from the baseline abundance 24 h after
sedation for either the wild type or the slo∆6b mutant. Unpaired t-test, n=3. Error bars represent SEM.
doi: 10.1371/journal.pone.0075549.g003
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Figure 4.  The slo∆6b mutant shows unusually long-lived benzyl alcohol tolerance.  A) Schematic of the paradigm used to
determine the time course of functional tolerance. A stock shows tolerance if it recovers more rapidly from its second sedation than
from its first sedation. A population of age-matched females were separated into two groups. One group was mock sedated and the
second group was sedated with benzyl alcohol. The animals were then housed in separate vials with food for the time intervals in
panel B (1d -28 d) and then both groups were benzyl alcohol sedated in tandem, moved to fresh air (t=0), and their recovery
recorded. B) The recovery curves describe the percentage of flies recovering after a single sedation (blue) and after a two
sequential sedations (red) that were separated by the time interval shown. Tolerance lasts for at least 28 d in slo∆6b; however, it is
detected in wild type for only a week. Error bars represent SEM, but significance difference between curves is determined by log-
rank analysis (n=4–6. *P ≤ 0.05).
doi: 10.1371/journal.pone.0075549.g004
A DNA Element That Modulates Drug Responses
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has been directly linked to the production of functional
tolerance to sedation [4]. The slo∆6b mutant overreacts to drug
sedation by producing an increased induction of slo expression
without changing the duration of induction. This molecular
overreaction appears to precipitate a rather substantial
increase in the behavioral response. The mutation vastly
exaggerates the duration of functional tolerance from ~10 days
to at least 28 days. Technical limitations prevent us from
assaying tolerance after this point, therefore twenty-eight days
is the lower limit on the duration of tolerance in the mutant.
The extra BK channels produced as a consequence of slo
induction could outlive the transient increase in slo message
abundance. However, it seems improbable that the mutant
allele could produce a sufficient superabundance of BK
channels in 24 h to maintain tolerance for the full 28 days. In
concordance with this supposition, the duration of the increase
in seizure susceptibility also suggests that the slo∆6b allele does
not cause a 28 d pan-neural increase in BK channel density
after drug sedation.
Drug-withdrawal phenotypes and functional tolerance have
been long proposed to have a common origin. This relationship
was first described in the homeostatic theory of tolerance and
dependence described by Himmelsbach [18] and refined by
Martin [19]. The idea here is that the same changes that
produce functional tolerance persist after drug clearance,
temporarily unbalancing the nervous system, to cause the
withdrawal symptom. Intrinsic to this idea is that the withdrawal
symptom is expected to be opposite to the effect of a drug.
Thus, a drug that depresses neural excitability is proposed to
trigger pro-excitatory changes that counter the effects of the
drug and result in tolerance. Once the drug is cleared, the
excitatory changes will be uncovered resulting in a
hyperexcitable nervous system. While this hypothesis probably
does not hold true for all drugs, in flies, the relationship of the
Figure 5.  The time course analysis of slo transcription in
slo∆6b flies.  The mRNA levels of slo were determined by real-
time RT-PCR using C1 primers that amplify only neural slo
transcripts. One-way ANOVA with Dunnett’s comparison post
test, n=3. Error bars represent SEM.
doi: 10.1371/journal.pone.0075549.g005
slo gene to benzyl alcohol functional tolerance and the benzyl
alcohol withdrawal symptom (lowered seizure threshold) are in
concert with the predictions of the hypothesis. In response to
benzyl alcohol sedation, the slo gene is induced with pro-
excitatory consequences (possible mechanisms described
below) and this shortens the duration of sedation by benzyl
alcohol [4]. The next day, long after benzyl alcohol clearance,
the excitatory change produced by slo induction persists and in
the absence of the drug causes the nervous system to be
hyperexcitable [5,20].
How can an increase in the expression of the slo BK channel
gene act as a neural excitant? The dogmatic view is that
increases in K+ channel activity always produces a decrease in
neural excitability and certainly, in some cells BK channel
activity reduces excitability [21]. However, it has also long been
known that in some cells BK channels have the opposite
relationship to excitability. It was first noted by Warbington et
al. [22] that, in flies, eliminating BK channel expression reduced
neurotransmitter release at the larval neuromuscular junction.
In mammals, BK channels are also the product of the slo gene.
In pituitary cells, BK channel activity was shown to have a
positive rather than a negative relationship to repetitive firing
[23,24]. This positive relationship between channel activity and
cellular excitability has also been documented in the
mammalian CNS. In the dentate gyrus, BK channel activity
increases the capacity for repetitive firing and a gain-of-function
mutation in the human slo gene even causes an epilepsy
[25-27]. In all of these mammalian examples, increased BK
channel activity causes the action potential to repolarize more
rapidly. This change prevents the inactivation of voltage-gated
Na+ channels, or the activation of other K+ channels (e.g. SK
channel) that would produce a long lasting after-depolarization
—either of which extends the refractory period of the neuron.
Thus, increasing BK channel activity increases net neuronal
excitability by shortening the refractory period.
The same positive correlation between slo BK channels and
neural excitability exists in flies. Ghezzi et al. [5] showed that
transgenic over expression of the slo BK channel gene
shortens the refractory period of the giant fiber pathway of
Drosophila and lowers the seizure threshold of the fly whereas
blocking slo expression was shown to increase the seizure
threshold [28]. The increased susceptibility to seizures is a
withdrawal phenotype because it is precipitated by a drug but is
only apparent after drug clearance. A similar withdrawal
phenotype has been observed for flies in benzyl alcohol
withdrawal and for flies in ethanol withdrawal [5,20].
BK channels expressed from the slo gene have also been
shown to underlie a form of functional ethanol tolerance
described in the rat hypothalamic-neurohypophysial explant
system [30]. In this system, ethanol potentiates BK channel
activity which leads to an increase in firing and a suppression
of hormone release. However, chronic ethanol exposure leads
to tolerance. Tolerance is produced by internalizing preexisting
BK channels and replacing them with ethanol-resistant
channels. The shift to the production of ethanol-resistant BK
channels has been documented in both the hypothalamo-
neurohypophysial and medium spiny neurons of rats and is
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caused by the activation of a microRNA (mir9) that targets slo
transcripts encoding ethanol-sensitive channels [31].
In mammalian model systems of slo-dependent ethanol
tolerance, transcriptional regulation has not been identified as a
key factor, nor has post-transcriptional regulation been
identified as important in the Drosophila model of organic
solvent tolerance. This may, however, be a product of the
different properties and experimental advantages offered by
each model system although it is also possible that different
organisms emphasize different regulatory regimens to achieve
related ends.
Because changes in slo expression underlie both functional
tolerance and the reduced seizure threshold withdrawal
phenotype, one would expect that the slo∆6b mutant would
affect tolerance and the seizure threshold phenotype in the
same way. While both responses are increased, it is the
duration of the tolerance phenotype that increases, while it is
the magnitude of the seizure phenotype that changes. Thus, in
a sense they both change in the same direction, however it is
not quite in the manner expected.
What might account for the difference in time course
between the effect of the mutation on the tolerance and seizure
phenotypes? Perhaps the amount of slo expression required to
produce the tolerance phenotype is lower than the expression
threshold required for the withdrawal phenotype. The turnover
rate of BK channels might then account for the difference in
duration of these two drug endophenotypes. An exponential
decay of the extra BK channels could cause channel activity to
fall below the threshold for seizure susceptibility before it drops
below the threshold for tolerance. Thus, a single change in
gene expression could produce both the relatively short change
in seizure threshold and the long lasting change in functional
Figure 6.  State of histone H4 acetylation across the slo transcriptional control region after benzyl alcohol sedation.  A)
Map of the slo transcriptional control region and areas assayed by the chromatin immunoprecipitation assay. Arrowheads identify
the position of the tissue-specific slo core promoters, and open boxes on the line represent exons. The gray boxes below the line
show the conserved elements tested in the chromatin immunoprecipitation assay. In slo∆6b, the 6b site was replaced by a loxP
element. B) H4 acetylation levels 6 h detected in WT and slo∆6b after benzyl alcohol sedation. One-way ANOVA with Dunnett’s
comparison post test. n=3. From left to right * signifies P=0.0458, 0.0278, and 0.0200. *** signifies P=0.0008. Fold change of
acetylation was the ratio of the acetylation levels of drug-sedated flies over untreated ones. C) Acetylation state surveyed 24 h after
BA sedation. One-way ANOVA with Dunnett’s comparison post test. n=3. From left to right * signifies P=0.0387, 0.0486, and
0.0239. Error bars represent SEM.
doi: 10.1371/journal.pone.0075549.g006
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tolerance. Alternatively, tolerance and the susceptibility to
seizure withdrawal phenotype may arise from different neural
structures with different turnover rates for the BK channel or
even different slo induction dynamics after drug sedation.
Perhaps the slo∆6b allele is persistently active in the structure
underlying tolerance but only transiently active in the
structure(s) responsible for the change in seizure threshold.
Because RT-qPCR does not detect overexpression throughout
Figure 7.  Electrophysiological analysis of wild type and slo∆6b stocks.  A) Electroconvulsive stimuli (ES) induce a stereotypical
seizure response from the giant fiber pathway. Constant low-frequency stimulations were applied continuously to assess the state of
responsivity of the giant fiber pathway. A seizure consists of a high-frequency initial discharge (ID) followed by a period in which the
giant fiber fails to respond to stimulation (Failure) followed by a delayed discharge (DD) and then by a recovery of normal
responsivity. The seizure threshold was identified by delivering electroconvulsive shock of varying voltage until the production of a
stereotypical seizure response. B) The slo∆6b mutant exhibited a significant lower average seizure threshold compared to wild-type
flies. Benzyl alcohol sedation reduced stimulus voltage in both stocks. C) The drug-induced reduction in seizure threshold was
greater in slo∆6b mutants than in wild-type animals one day after sedation. D,E) The average seizure stimulus voltages of both WT
and slo∆6b returned to baseline at 7 d after sedation. F) Time course of seizure threshold after drug sedation. Re-plot of the data
presented in panels B-E to illustrate the convergence of seizure threshold as a function of age. Wild-type (WT) and slo∆6b lines are
compared before and after benzyl alcohol (BA) sedation. Unpaired Student’s t-test, P values and number of repeats as shown. Error
bars show SEM.
doi: 10.1371/journal.pone.0075549.g007
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the period of tolerance, this overexpressing structure would
have to be small and/or the level of induction would have to be
small. The lack of synchrony in the duration of tolerance and
withdrawal phenotypes might also be the product of cellular- or
system-level adaptions to increased BK channel activity that
differentially affect these two phenotypes. Finally, the apparent
disconnection between the duration of these phenotypes could
merely be a side-effect of an age-related change. Indeed, in
the wild type we observed an age-related reduction in seizure
threshold (Figure 7F). It is possible that this reduction
eventually obscures any drug-mediated reduction in seizure
susceptibility.
The observation that the slo∆6b allele depresses the baseline
seizure threshold means that the mutant must alter the
expression pattern of slo even in the absence of benzyl alcohol
exposure. However, if the alteration occurs in the adult then it
must be subtle given that the change is not detectable by RT-
qPCR. This might occur in multiple ways. The mutant allele
could produce a tiny pan-neuronal change in expression that is
sufficient to produce the phenotype. It could also be that the
mutation alters expression in a specific but tiny part of the
nervous system and this lowers the seizure threshold.
Alternatively, the mutation may produce a change in
expression during development that reduces the seizure
threshold in the adult nervous system even though slo
expression in the adult is normal.
The 6b element was identified as a candidate element
because it underlies a drug-induced histone acetylation spike.
In the wild type, increased histone acetylation persisted over 6b
for 24 h after benzyl alcohol sedation. Furthermore, the HDAC
inhibitor sodium butyrate induced slo expression, phenocopied
tolerance, and generated a single acetylation spike over
element 6b [6]. This led us to hypothesize that a histone
deacetylase was chronically positioned at 6b and that perhaps
the regulation of this deacetylase contributed to slo induction.
The response of the slo∆6b mutants to benzyl alcohol sedation
suggests that this interpretation is correct—that 6b is a
negative regulator of slo expression, albeit it is possible that it
is not the absence of 6b that produces the phenotype but
instead small changes in the spacing between elements that
flank 6b.
Examination of the 6b element shows that it contains
transcription factor binding site motifs that might account for
this mutant phenotype. Within 6b there is a heat shock element
(HSE) motif that could be recognized by the heat-shock
regulatory transcription factor (HSF) [6]. HSF has been shown
to regulate histone acetylation levels in mammals through its
association with HDAC1 and HDAC2 [29]. In a homologous
manner a Drosophila HSF transcription factor might help to
position HDACs at 6b. Deletion of the 6b element might
permanently prevent the positioning of regulatory HDACs that
are used to limit or terminate homeostatic activation of the slo
gene, and thereby the mutant overresponds to induction by
benzyl alcohol.
Histone modifications serve as molecular footprints that
visualize the action of transcription factors. This study
demonstrates the profound utility of epigenetic histone
modifications to map the position of DNA elements that
mediate specific regulatory responses. The map of the dynamic
histone modification changes induced by drug exposure helped
to narrow the search for a regulatory DNA element that
mediated the drug-induced change in transcription. It is unlikely
that the 6b element would have been identified as functionally
interesting by any other method of sequence analysis.
Materials and Methods
Fly stocks
Drosophila stocks were Canton S (wild type), slo4, and slo∆6b.
Flies were raised on standard cornmeal medium in a 12/12
light/dark cycle at 22°C. Newly eclosed flies collected during a
2 d time period were studied 4–5 days after eclosion.
Ends-out gene targeting of the 6b element
The homologous recombination method of Gong and Golic
[7] was used to precisely replace the ~60 nt 6b element with a
80 nt loxP sequence. The two flanking DNA fragments of the
slo 6b element were amplified by PCR with Canton S genomic
DNA template and proofreading PfuTurbo DNA polymerase
(Stratagene CA) and inserted into the ends-out vector pW25
[32]. Primers 5'-gcggccgcgagggatgctgctgctttac-3' and 5'-
gcggccgcattctcgccgtttttaaattctcag-3' were used in the PCR to
amplify and add NotI sites to both ends of a 3.26 kb DNA
fragment upstream of the 6b element, while primers 5'-
ggcgcgccttgacacgcttgcttttccggcta-3' and 5'-
ggcgcgccaagttggcccagtttgtttg-3' were designed to amplify and
add AscI termini to a 3.03 kb DNA fragment downstream of 6b.
These two donor fragments were then inserted into the
corresponding sites of pW25 with the same orientation. The 6b
deletion construct was introduced into a w1118 background by P
element germ line transformation. The chromosomal insertion
of the donor transgene was genetically mapped, and lines with
the transgene on the first or the second chromosome were
utilized to induce targeting on the third chromosome.
The scheme for targeted replacement of the 6b is shown in
Figure 1. To induce targeting, donor insertion lines are crossed
to the P{hsp70FLP} P{hsp70I-SceI} strain (Bloomington #
6934). The progeny were heat shocked during the first 3 days
of development to induce FLP and SceI expression. The heat
shock was 38°C for 1 h. Females with donor and P{hsp70FLP}
P{hsp70I-SceI} were crossed to male FLP flies (Bloomington #
6938), and the progeny were screened for solid red eyes. The
transgenic w+ gene was mapped to identify targeting events in
which w+ was relocated to the target chromosome 3. Finally,
the targeted strain was crossed to P{Cre} line (Bloomington #
1501) to remove the w+ marker and generate the 6b deletion
mutant slo∆6b. The sequence of the modified gene has the
Genbank accession # KF514522.
Southern blotting analysis
Southern blot analyses were performed using a DIG kit
(Roche Diagnostics, IN). Genomic DNA was digested overnight
with BsoBI (NEB Inc., MA) and subjected to agarose gel
electrophoresis and nylon membrane transfer as described
[33]. The DNA probe was a 0.6 kb fragment of the slo promoter
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region prepared by PCR with primers 5'-
GCGACCACAAATCGTCCAAACACA-3' and 5'-
TAGCACTGCGAACTATCGCTGGAA-3'. The blot was
hybridized to the digoxigenin (DIG) labelled probe and
visualized with DIG antibody-coupled chemiluminescence.
Benzyl alcohol sedation
Benzyl alcohol sedation of ten 3–5 d old female flies was
conducted as described [4]. Briefly, 30 ml glass vials were
coated with 200 µl of 0.4% benzyl alcohol in acetone and then
rotated constantly for 20 min to evaporate the more volatile
acetone and leave a layer of benzyl alcohol on the wall. In
contrast, the vials for controls were coated with acetone only,
which was completely evaporated to dryness after 20 min.
Animals were transferred into either the benzyl alcohol vials or
the control vials until all the flies in the drug vials were
completely sedated (usually 5-10 min). After exposure, flies
were moved back to food vials for recovery.
Tolerance assay
The capacity to acquire tolerance was measured as
described [4]. Recently eclosed females were divided into
groups of 10. In the first exposure, half were sedated with 0.4%
BA, and half were mock sedated with acetone. On the day of
assay, all groups were sedated with 0.4% BA and transferred
to fresh vials to recover. Flies were scored as recovered when
they resumed climbing. The whole course of recovery was
analyzed by a computer-controlled automated movement
detection system [34]. The recovery curves were plotted as the
percentage of recovered flies against time.
Chromatin immunoprecipitation (ChIP) assay
ChIP assays were performed using the Upstate/Millipore
ChIP kit. Approximately 1,000 flies were either benzyl alcohol
sedated or mock sedated for 6–8 minutes and then allowed to
recover in a drug-free environment. Six hours and 24 h after
sedation, flies were frozen in liquid nitrogen, and heads were
harvested by vortex decapitation and sieving. Chromatin was
prepared as described5, sheared to ~600 bp and precipitated
using a polyclonal antibody against histone H4 acetylated at
K5, K8, K12, and K16 (part 06-866, Upstate/Millipore) at 1:200
dilution. Total DNA was measured in one-tenth of the lysate for
normalization purposes. ChIP assays were performed at least
three times with independent chromatin samples.
Real-time PCR was performed using the ABI SYBR Green
PCR Master Mix (Applied Biosystems) with an ABI 7300 real-
time PCR system (Applied Biosystems). Primers were
designed to amplify 100~200 bp fragments of the slo
transcriptional control region, including the two neural
promoters (C0, C1), the muscle promoter (C2), and five
evolutionarily conserved regions (4b, 6b/loxP, cre1, 55b, and
cre2). Genes Gpdh (Glycerol-3-phosphate dehydrogenase)
and Cyp1 (Cyclophilin 1) were used as internal controls
because their transcription and acetylation levels are




















GCCCTGAAAAGTGCAAGAAG-3'); and Cyp1 (5'-
TCTGCGTATGTGTGGCTCAT-3', 5'-
TACAGAACTCGCGCATTCAC-3'). The PCR protocol began
with a denaturation cycle of 95 °C/5 min, followed by 40 cycles
of 95 °C/15 s, 60 °C/30 s, and ended with a single cycle of 72
°C/30 s. Real-time PCR amplifications were run in duplicate,
and the dissociation/melting curves were used to detect
nonspecific amplifications. The relative amount of the DNA
precipitated by the H4Ac antibody was determined by ∆∆Ct
method. Fold enrichment of H4 acetylation of the drug-sedated
group equals 2^(∆Ctctrl - ∆CtBA) where ∆Ct = CtIP - CtInput.
Reverse transcription-quantitative PCR analysis
RNA was extracted from heads as described [4]. Reverse
transcription and real-time PCR were performed in triplicate
with slo exon C0, C1, and Cyclophilin 1 (Cyp1) primers [17].
Relative RNA quantity was calculated using the standard curve
method. Forward and reverse primers were as follows: for slo
exon C0, 5'-ATACGCTGCTGACGAGAAAGGTTG-3' and 5'-
ACTGCGCTTAGTCACACTGCTCAT-3'; for slo exon C1, 5'-
AAACAAAGCTAAATAAGTTGTGAAAGGA-3' and 5'-
GATAGTTGTTCGTTCTTTTGAATTTGA-3'; and for Cyp1, 5'-
ACCAACCACAACGGCACTG-3 and 5'-
TGCTTCAGCTCGAAGTTCTCATC-3'.
Walking and climbing assay
Walking speed was measured with females in a 12-well (35
mm x 5 mm) culture plate. A single fly was placed in each well
and allowed 5 minutes to equilibrate, and then activity was
recorded in a 10 min video recorded with a webcam. Eight 4 s
videos clips of walking flies were manually measured to
determine the distance traversed.
The climbing assay was conducted as described to measure
relative activity of flies [35]. Three groups of 12 flies each were
placed in a 20 mm × 150 mm glass test tube and gently tapped
to the bottom. The number of flies that climbed beyond 10 cm
within 10 sec was counted.
Flight assay
The flight capacity of animals was determined as previously
described for slo mutants [36]. Approximately 500 flies were
dropped into the center of a mineral oil–coated 15 cm × 62 cm
A DNA Element That Modulates Drug Responses
PLOS ONE | www.plosone.org 11 September 2013 | Volume 8 | Issue 9 | e75549
pipette jar through a funnel at the top. The falling animals fly
from the center and are trapped in the oil. The distance that
they fall is correlated with the capacity for flight. The position of
each fly was marked and its distance from the top was
measured. Flies with good flight capacity clustered near the top
of the jar, whereas flies that flew poorly stayed close to the
bottom.
Sticky-feet behavioral assay
The sticky-feet behavioral test was performed as described
[36]. Briefly, flies were heat-shocked in a glass vial at 37°C for
7 min. Animals were then transferred to the benchtop and left
undisturbed for about 10 sec. A flat toothpick was used to push
on the sides of the flies. Sticky-feet is defined as when a fly
hangs onto the surface instead of flying or walking away.
Circadian rhythm assay
Flies were raised in a rhythmic 12:12 light:dark cycle. Males
were individually loaded, without anesthesia, into 5 mm × 65
mm glass tubes with 5% sucrose 2% agar food at one end.
These tubes were then loaded into Drosophila Activity Monitors
(DAM2, Trikinetics, Waltham MA) that detect movement using
infrared sensors. The monitors were placed into a sound-
isolated incubator at 24°C, and free-running rhythms were
measured in constant darkness in 5 minute bins for 14 days.
Any fly that did not move for any 24 hour period in the first ten
days was discarded from analysis. Period and rhythm indices
were generated by the autocorrelation as described [37].
Rhythmic animals were those with a rhythm index greater than
0.1 [38]. Average daily activity was determined by summing
and then averaging the number of DAM2 beam passes over a
7 day period.
Seizure susceptibility analysis
Seizure susceptibility was measured by determining the
seizure threshold of the giant fiber pathway as described [5].
Briefly, a female was mounted on a stereoscope stage in a
small mount of paraffin wax. Two stimulating 200 µm diameter
sharpened tungsten wire electrodes (FHC Inc.) were inserted
through the anterior face of the head on each side, between
the compound eyes and the antennal sockets, halfway through
the head into the brain of the fly using micromanipulators
(Narishige, Inc.). Similarly, a sharpened 75 µm diameter
recording electrode was inserted into the upper most DLM flight
muscle through the dorsal thoracic cuticle while a sharpened
200 µm diameter reference electrode was placed in the
abdomen. Stimuli were generated using a S48 square pulse
stimulator, isolated with a SIU5 Stimulus Isolation Unit (Grass-
Telefactor). Responses from the DLM were amplified with a
Microelectrode Amplifier Model 1800 (A-M Systems) and
digitized by a DigiData 1200 (Axon instruments). Data were
recorded and analyzed in a PC using FETCHEX pCLAMP 6
software (Axon instruments).
Low-frequency (0.2 Hz) stimulating 30 V pulses were applied
to the brain continuously to assess the health of the giant-fiber
pathway. Successful responses to each stimulus pulse were
detected at the DLM by the recording electrode as sharp action
potential-like depolarizations. For each fly, seizures were
triggered by 1.5 s long 200 Hz electro-convulsive shock (ECS)
pulses of increasing voltage at 10 V steps in 8-minute intervals
until a stereotypical seizure was elicited (Figure 6A).
Statistical analysis
In the tolerance assay, the log-rank test for equality of
survival was used to determine the significance between
sedation recovery curves [39]. This statistic is well-suited for
evaluating differences in the time to an event (such as
recovery). The statistic evaluates whether entire recovery
curves are different and not whether differences exist at any
single time point.
In the ChIP analysis, the entire protocol was repeated at
least three times, and significance was determined by one-way
ANOVA. For RT-qPCR (n=3) and for changes in seizure
threshold (n=5-9), significance was determined using an
unpaired Student’s t test. Statistical significance in the daily
activity (n=25), walking speed (n=3), and climbing assay (n=4)
were determined by one-way ANOVA and Dunnett’s post-hoc
analysis.
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